Table 4.
Projections of hepatocellular carcinoma incidence to 2028 in Korea
| Number of new cases |
Crude rate (per 100,000 person-years) |
Age-standardized rate (per 100,000 person-years) |
|||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2008 | 2028 | Change in numbers (%) | 2008 | 2028 | Changes in crude rate (%) | 2008 | 2028 | Changes in ASR (%) | Annual percent change | 95% CI | |
| All | 12,056 | 9,663 | -19.8 | 23.9 | 17.9 | -25.3 | 21.9 | 9.7 | -55.8 | -3.9* | -4.0 to -3.8 |
| Men | 9,422 | 7,264 | -22.9 | 37.3 | 26.7 | -28.4 | 33.7 | 14.3 | -57.6 | -4.1* | -4.2 to -4.0 |
| Women | 2,634 | 2,399 | -8.9 | 10.5 | 8.9 | -15.1 | 9.6 | 4.1 | -57.0 | -4.0* | -4.1 to -3.9 |
| 0–29 years | 75 | 5 | -93.3 | 0.4 | 0.05 | -87.5 | 0.4 | 0.01 | -97.0 | -15.7* | -16.6 to -14.8 |
| 30–59 years | 5,861 | 1,635 | -72.1 | 24.7 | 7.0 | -71.7 | 25.8 | 15.5 | -39.8 | -2.7* | -2.8 to -2.6 |
| 60–79 years | 5,599 | 5,968 | 6.6 | 87.2 | 42.9 | -50.8 | 97.5 | 103.2 | 5.8 | 0.6* | 0.5 to 0.6 |
| ≥80 years | 521 | 2,055 | 294.4 | 58.5 | 82.2 | 40.5 | 70.0 | 387.6 | 453.5 | 9.3* | 9.2 to 9.3 |
ASR, age-standardized incidence rate; CI, confidence interval.
*
Refers to P<0.05.